CompaniesPhytoMedical

PhytoMedical

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

86

By Phase

PHASE1/PHASE2: 3

By Status

COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00076609
Hover over trial bars to see details

Recent Trials

NCT00411762Collaborator
A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
PHASE1/PHASE2Completed
25 participants
Started: Dec 31, 2006 · Completed: Dec 31, 2009
NCT00076609Lead Sponsor
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
PHASE1/PHASE2Completed
31 participants
Started: Oct 31, 2003
NCT00036517Lead Sponsor
Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
PHASE1/PHASE2Terminated
30 participants
Started: Feb 28, 2002 · Completed: Mar 31, 2003
Funding History (20)
8-K
May 1, 2013
Filing
S-1
Sep 24, 2012
Filing
8-K
Aug 21, 2012
Filing
8-K/A
Mar 15, 2012
Filing
8-K
Feb 6, 2012
Filing
8-K
Jan 5, 2012
Filing
8-K
Nov 29, 2011
Filing
8-K
Nov 10, 2011
Filing
DEF 14A
Sep 15, 2011
Filing
8-K
Jul 18, 2011
Filing